You are here

Article Text

Article menu
Download PDFPDF
Quality Improvement
Review: most disease management programmes for providers and patients lead to improvements in care

https://doi.org/10.1136/ebm.8.2.64

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2002) BMJ 325, 925. Weingarten SR, Henning JM, Badamgarav E, et al.. Interventions used in disease management programmes for patients with chronic illness—which ones work? Meta-analysis of published reports.. ;. :. –8.
    OpenUrlAbstract/FREE Full Text

    
 
 QUESTION: What is the effectiveness of provider and patient targeted interventions used in disease management programmes for patients with chronic illness?

    Data sources

    Studies were identified by searching Medline, HealthSTAR, and the Cochrane Database from January 1987 to June 2001; hand searching bibliographies of relevant articles and reviews; and consulting experts in the field.

    Study selection

    English language controlled clinical trials that evaluated the effectiveness of disease management programmes in improving care or reducing costs and potentially using multiple treatment methods for patients with common chronic conditions were selected for review. Studies were excluded if they did not use acceptable experimental or quasi-experimental design; exclusively evaluated single treatment methods or drug compliance programmes; or did not report sufficient information to allow for estimation of ≥1 relevant measure of programme effect and its variance.

    Data extraction

    Data were …

    View Full Text

    Footnotes

    • For correspondence: Dr S Weingarten, Zynx Health, Beverly Hills, CA, USA. sweingarten{at}cerner.com

    • Abstract and commentary also appear in ACP Journal Club.

    • Source of funding: TAP Pharmaceutical Products.